Jenny McGovern
Senior Director Quell Therapeutics
Seminars
Wednesday 25th February 2026
Uncovering the Potential of CD19 CAR-Tregs: Pre- Clinical Data Driving the Next Wave of Treg Therapies
2:00 pm
- Evaluate CD19 CAR-Treg design, function, and in preliminary data
- Understand how pre-clinical results inform translational and clinical readiness
New Data
